Header graphic for print
MoFo Tech A blog dedicated to information, trend spotting & analysis for science- & tech-based companies

Category Archives: Biotech

Subscribe to Biotech RSS Feed

Good Chemistry

Thanks to a merger, a poultry and produce wash is helping the oil industry extract resources more effectively In 2008, Vic Keasler was performing molecular biology tests at a pharma, biotech, and academic research company.  Keasler had studied hepatitis B and C’s effect on liver cancer in graduate school; his career had primarily focused on… Continue Reading

Biotech: Let’s Make a Deal

Scientific acumen is crucial—but so is an understanding of today’s deal market. The risks and costs of life sciences product development have become so high that few companies are willing to bear them on their own. As partnerships become vital, skill in dealmaking has become almost as vital as scientific acumen for today’s pharma and… Continue Reading

MoFo BioMeter Shows Decline in Biotech Licensing Payments

The third issue of MoFo BioMeter, which covers the first quarter of 2013, has launched. MoFo BioMeter reports that the average value for all biotech licensing transactions in the first quarter was an impressive $60 million – a sizable jump over 2012’s Q1. However, much of that stems from two outsized deals – the BMS/Reckitt… Continue Reading

Sharing an Umbrella

Big Pharma and academia cement big deals in the quest for bigger prizes With the patents of many highly profitable blockbuster drugs expiring over the course of a few years, the search is on for new drugs to fill large pharmaceutical companies’ shrinking product portfolios. For years, Big Pharma has turned to smaller biotech companies… Continue Reading

MoFo BioMeter Report for Q4 and Full Year 2012

The fourth quarter of 2012 saw an uptick in BioMeter value, with an average BioMeter value of approximately $26.8 million for license and collaboration agreements announced during the quarter, led by an increase in BioMeter values for Phase 2 transactions and a single high-value transaction for an approved product. Transactions for Phase 2 and pre-clinical/discovery… Continue Reading

Introducing the MoFo BioMeter

Morrison & Foerster is pleased to introduce the MoFo BioMeter™, an index developed to measure the health of the biotechnology industry. BioMeter takes the pulse of the industry by looking at a key measure of deal value—up-front payments—for deals in all stages of development. We also offer insight on the data and the potential impacts… Continue Reading

A Breed Apart

Crop inventors are seeking to protect their work, even if they don’t use GMOs When international seed supplier Enza Zaden bred a delicious and juicy new tomato in the 1990s, the world was introduced to the now famous Campari. The globe-shaped vegetable soon became a supermarket staple, but the Dutch company did not patent its… Continue Reading